Filament Health Corp (FH) - Total Liabilities
Based on the latest financial reports, Filament Health Corp (FH) has total liabilities worth CA$1.94 Million CAD (≈ $1.40 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Filament Health Corp - Total Liabilities Trend (2020–2024)
This chart illustrates how Filament Health Corp's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Filament Health Corp to evaluate short-term liquidity relative to the company's equity base.
Filament Health Corp Competitors by Total Liabilities
The table below lists competitors of Filament Health Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Luxbright AB
ST:LXB
|
Sweden | Skr12.49 Million |
|
Chinhung International Inc
KO:002785
|
Korea | ₩253.44 Billion |
|
Alliance Mining Corp
V:ALM
|
Canada | CA$3.73 Million |
|
TELES Informationstechnologien AG
XETRA:TLIK
|
Germany | €4.29 Million |
|
Spectra Inc.
V:SSA
|
Canada | CA$354.95K |
|
Cariboo Rose Resources Ltd
V:CRB
|
Canada | CA$117.64K |
|
Phoenix Spree Deutschland Ltd
LSE:PSDL
|
UK | GBX312.33 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Filament Health Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Filament Health Corp.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Filament Health Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Filament Health Corp (2020–2024)
The table below shows the annual total liabilities of Filament Health Corp from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$1.66 Million ≈ $1.20 Million |
-46.02% |
| 2023-12-31 | CA$3.08 Million ≈ $2.23 Million |
+99.35% |
| 2022-12-31 | CA$1.55 Million ≈ $1.12 Million |
+19.99% |
| 2021-12-31 | CA$1.29 Million ≈ $932.83K |
+1798.69% |
| 2020-12-31 | CA$67.92K ≈ $49.13K |
-- |
About Filament Health Corp
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provide… Read more